Skip to main content
Clinical Trials/CTRI/2023/10/059236
CTRI/2023/10/059236Not yet recruitingPhase 3

Effectiveness of Individualized Homoeopathic Medicine in Cervical Lymphadenopathy in children- Pilot, Open label study

Central Council for Research in Homoeopathy4 sites in 1 country130 target enrollmentStarted: January 11, 2023Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
130
Locations
4
Primary Endpoint
Change in number,location & size of the cervical lymph nodes

Study Overview

Brief Summary

The multicentric, Pilot, Open-label, Interventional Study will be undertaken at the 4 peripheral units of CCRH with an objective to evaluate the effectiveness of individualized homeopathic medicine in cervical lymphadenopathy in children, to assess the change in number, location and size of the enlarged cervical lymph nodes , to assess the effectiveness of the individualized Homoeopathic medicines along with Silicea 6x (as a supportive medicine) and Tuberculinum 200 (as an intercurrent nosode) in children who are not responding to only individualized homoeopathic medicines/refractory cases of Tubercular Lymphadenitis. The outcome assessment parameters will be assessed every fortnightly by evaluating the change in number, location, size,mobility and consistency till end of 6 months.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Open Label

Eligibility Criteria

Ages
5.00 Year(s) to 17.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Children between 5 to 17 years,Sex: Both male and female,Single or multiple enlarged cervical lymph nodes or enlarged unilateral or bilateral cervical lymph node, At least 1 cervical lymph node should be more than 1 cm or palpable,Assent of children and consent of parents.

Exclusion Criteria

  • Children suffering from Pulmonary Tuberculosis, Hodgkin’s lymphoma, malignancy, autoimmune disease Children on Anti Tubercular Treatment (ATT) in the last 6 months.
  • Lymph node less than 1cm in size or at any other site such as inguinal or axillary areas.

Outcomes

Primary Outcomes

Change in number,location & size of the cervical lymph nodes

Time Frame: Assessed fortnightly till end of 6 months

Secondary Outcomes

  • Change in mobility(Change in consistency)

Investigators

Sponsor
Central Council for Research in Homoeopathy
Sponsor Class
Research institution

Study Sites (4)

Loading locations...

Similar Trials